-
1
-
-
34247646400
-
The incidence and impact of thrombo-cytopenia in myelodysplastic syndromes
-
Kantarjian H, Giles F, List A et al. The incidence and impact of thrombo-cytopenia in myelodysplastic syndromes. Cancer 2007;109:1705-1714.
-
(2007)
Cancer
, vol.109
, pp. 1705-1714
-
-
Kantarjian, H.1
Giles, F.2
List, A.3
-
2
-
-
0030897009
-
International scoring system for evaluating prognosisin myelodysplastic syndromes
-
Greenberg P, Cox C, LeBeau MM et al. International scoring system for evaluating prognosisin myelodysplastic syndromes. Blood 1997;89:2079-2088.
-
(1997)
Blood
, vol.89
, pp. 2079-2088
-
-
Greenberg, P.1
Cox, C.2
Lebeau, M.M.3
-
3
-
-
34548219420
-
Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelo-dysplastic syndromes
-
Malcovati L, Germing U, Kuendgen A et al. Time-dependent prognostic scoring system for predicting survival and leukemic evolution in myelo-dysplastic syndromes. J Clin Oncol 2007;25:3503-3510.
-
(2007)
J Clin Oncol
, vol.25
, pp. 3503-3510
-
-
Malcovati, L.1
Germing, U.2
Kuendgen, A.3
-
4
-
-
47249150213
-
Epidemiologyof myelodysplas-tic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs
-
Rollison DE, Howlader N, Smith MT et al. Epidemiologyof myelodysplas-tic syndromes and chronic myeloproliferative disorders in the United States, 2001-2004, using data from the NAACCR and SEER programs. Blood 2008;112:45-52.
-
(2008)
Blood
, vol.112
, pp. 45-52
-
-
Rollison, D.E.1
Howlader, N.2
Smith, M.T.3
-
5
-
-
34247172535
-
Myelodysplastic syndromes: Incidence and survival in the United States
-
Ma X, Does M, Raza A et al. Myelodysplastic syndromes: Incidence and survival in the United States. Cancer 2007;109:1536-1542.
-
(2007)
Cancer
, vol.109
, pp. 1536-1542
-
-
Ma, X.1
Does, M.2
Raza, A.3
-
6
-
-
77956397358
-
Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries
-
Goldberg SL, Chen E, Corral M et al. Incidence and clinical complications of myelodysplastic syndromes among United States Medicare beneficiaries. J Clin Oncol 2010;28:2847-2852.
-
(2010)
J Clin Oncol
, vol.28
, pp. 2847-2852
-
-
Goldberg, S.L.1
Chen, E.2
Corral, M.3
-
7
-
-
77950526605
-
The epidemiology of myelodysplastic syndromes
-
Sekeres MA. The epidemiology of myelodysplastic syndromes. Hematol Oncol Clin North Am 2010;24:287-294.
-
(2010)
Hematol Oncol Clin North Am
, vol.24
, pp. 287-294
-
-
Sekeres, M.A.1
-
8
-
-
55749114037
-
Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys
-
Sekeres MA, Schoonen WM, Kantarjian H et al. Characteristics of US patients with myelodysplastic syndromes: Results of six cross-sectional physician surveys. J Natl Cancer Inst 2008;100:1542-1551.
-
(2008)
J Natl Cancer Inst
, vol.100
, pp. 1542-1551
-
-
Sekeres, M.A.1
Schoonen, W.M.2
Kantarjian, H.3
-
9
-
-
13444256401
-
Efficacy of lenalidomide in myelodysplastic syndromes
-
List A, Kurtin S, Roe DJ et al. Efficacy of lenalidomide in myelodysplastic syndromes. N Engl J Med 2005;352:549-557.
-
(2005)
N Engl J Med
, vol.352
, pp. 549-557
-
-
List, A.1
Kurtin, S.2
Roe, D.J.3
-
10
-
-
0037093195
-
Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the Cancer and Leukemia Group B
-
Silverman LR, Demakos EP, Peterson BL et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: A study of the Cancer and Leukemia Group B. J Clin Oncol 2002;20:2429-2440.
-
(2002)
J Clin Oncol
, vol.20
, pp. 2429-2440
-
-
Silverman, L.R.1
Demakos, E.P.2
Peterson, B.L.3
-
11
-
-
33646071894
-
Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study
-
Kantarjian H, Issa JP, Rosenfeld CS et al. Decitabine improves patient outcomes in myelodysplastic syndromes: Results of a phase III randomized study. Cancer 2006;106:1794-1803.
-
(2006)
Cancer
, vol.106
, pp. 1794-1803
-
-
Kantarjian, H.1
Issa, J.P.2
Rosenfeld, C.S.3
-
12
-
-
0037541576
-
Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes
-
Jansen AJ, Essink-Bot ML, Beckers EA et al. Quality of life measurement in patients with transfusion-dependent myelodysplastic syndromes. Br J Haematol 2003;121:270-274.
-
(2003)
Br J Haematol
, vol.121
, pp. 270-274
-
-
Jansen, A.J.1
Essink-Bot, M.L.2
Beckers, E.A.3
-
13
-
-
40049097939
-
Common troublesome symptoms and their impact on quality of life in patients with myelodysplas-tic syndromes (MDS): Results of a large internet-based survey
-
Steensma DP, Heptinstall KV, Johnson VM et al. Common troublesome symptoms and their impact on quality of life in patients with myelodysplas-tic syndromes (MDS): Results of a large internet-based survey. Leuk Res 2008;32:691-698.
-
(2008)
Leuk Res
, vol.32
, pp. 691-698
-
-
Steensma, D.P.1
Heptinstall, K.V.2
Johnson, V.M.3
-
14
-
-
71049152788
-
Valuation of transfusion-free living in MDS: Results of health utility interviews with patients
-
Szende A, Schaefer C, Goss TF et al. Valuation of transfusion-free living in MDS: Results of health utility interviews with patients. Health Qual Life Outcomes 2009;7:81.
-
(2009)
Health Qual Life Outcomes
, vol.7
, pp. 81
-
-
Szende, A.1
Schaefer, C.2
Goss, T.F.3
-
15
-
-
79959579120
-
Measuring Healthy Days
-
Centers for Disease Control and Prevention, Atlanta, GA: Centers for Disease Control and Prevention, accessed May 28, 2010
-
Centers for Disease Control and Prevention. Measuring Healthy Days. Population Assessment of Health-Related Quality ofLife. Atlanta, GA: Centers for Disease Control and Prevention, 2000. Available at http://www.cdc.gov/hrqol/pdfs/mhd.pdf, accessed May 28, 2010.
-
(2000)
Population Assessment of Health-Related Quality OfLife
-
-
-
16
-
-
36049026124
-
Response rate and completeness of questionnaires: A randomized study of internet versus pa-per-and-pencil versions
-
Kongsved SM, Basnov M, Holm-Christensen K et al. Response rate and completeness of questionnaires: A randomized study of internet versus pa-per-and-pencil versions. J Med Internet Res 2007;9:e25.
-
(2007)
J Med Internet Res
, vol.e25
, pp. 9
-
-
Kongsved, S.M.1
Basnov, M.2
Holm-Christensen, K.3
-
17
-
-
62849104641
-
Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study
-
Fenaux P, Mufti GJ, Hellstrom-Lindberg E et al. Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: A randomised, open-label, phase III study. Lancet Oncol 2009;10:223-232.
-
(2009)
Lancet Oncol
, vol.10
, pp. 223-232
-
-
Fenaux, P.1
Mufti, G.J.2
Hellstrom-Lindberg, E.3
-
18
-
-
23044440179
-
Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF
-
Jädersten M, Montgomery SM, Dybedal I et al. Long-term outcome of treatment of anemia in MDS with erythropoietin and G-CSF. Blood 2005; 106:803-811.
-
(2005)
Blood
, vol.106
, pp. 803-811
-
-
Jädersten, M.1
Montgomery, S.M.2
Dybedal, I.3
-
19
-
-
33947499579
-
Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes
-
Golshayan AR, Jin T, Maciejewski J et al. Efficacy of growth factors compared to other therapies for low-risk myelodysplastic syndromes. Br J Haematol 2007;137:125-132.
-
(2007)
Br J Haematol
, vol.137
, pp. 125-132
-
-
Golshayan, A.R.1
Jin, T.2
Maciejewski, J.3
-
20
-
-
0023777523
-
Cancer patients' perceptions of their disease and its treatment
-
Mackillop WJ, Stewart WE, Ginsburg AD et al. Cancer patients' perceptions of their disease and its treatment. Br J Cancer 1988;58:355-358.
-
(1988)
Br J Cancer
, vol.58
, pp. 355-358
-
-
Mackillop, W.J.1
Stewart, W.E.2
Ginsburg, A.D.3
-
21
-
-
0038352135
-
Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication
-
Meropol NJ, Weinfurt KP, Burnett CB et al. Perceptions of patients and physicians regarding phase I cancer clinical trials: Implications for physician-patient communication. J Clin Oncol 2003;21:2589-2596.
-
(2003)
J Clin Oncol
, vol.21
, pp. 2589-2596
-
-
Meropol, N.J.1
Weinfurt, K.P.2
Burnett, C.B.3
-
22
-
-
79953734876
-
Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot study
-
2010 May 26 [Epub ahead of print]. DOI: 10.1002/ pon.1770
-
Smith SK, Herndon JE, Lyerly HK et al. Correlates of quality of life-related outcomes in breast cancer patients participating in the Pathfinders pilot study. Psychooncology 2010 May 26 [Epub ahead of print]. DOI: 10.1002/ pon.1770.
-
Psychooncology
-
-
Smith, S.K.1
Herndon, J.E.2
Lyerly, H.K.3
-
23
-
-
33750020532
-
South Thames Haematology Specialist Committee. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England
-
Phekoo KJ, Richards MA, Mller H et al.; South Thames Haematology Specialist Committee. The incidence and outcome of myeloid malignancies in 2,112 adult patients in southeast England. Haematologica 2006;91: 1400-1404.
-
(2006)
Haematologica
, vol.91
, pp. 1400-1404
-
-
Phekoo, K.J.1
Richards, M.A.2
Mller, H.3
|